A significant advance in cancer research is emerging with the use of mini-antibodies to reactivate damaged p53. This crucial cancer inhibitor protein is frequently inactivated in many types of cancer, resulting https://ticketsbookmarks.com/story21847457/mini-antibodies-revive-tumor-suppressor-p53-a-promising-pathway-for-malignant-management